Comparison the Effects of Two Doses of Intravenous Tranexamic Acid on Blood loss and Feild of the surgery during Endoscopic Sinus Surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201203242963N7

Enrollment

Registered

2012-04-06

Start date

2011-09-13

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tranexamic acid. Thrombolytic drugs

Interventions

Intervention 1: Intravenous tranexamic acid 5 mg/kg. Intervention 2: Intravenous tranexamic acid 15 mg/kg.

Treatment - Drugs

Intravenous tranexamic acid 5 mg/kg

Intravenous tranexamic acid 15 mg/kg

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ASA physical status I or II,18-50 aged candidates for endoscopic sinus surgery under general anesthesia Exclusion criteria:Coagulation disorder,history of hypertension,CVA,deep venous thrombosis,coronary artery disease,pulmonary emboli,and peripheral vascular disease.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Amount of blood loss. Timepoint: at the end of the surgery. Method of measurement: The amount of blool in the suction device and the number of blood-soaked gauze.	—

Secondary

Measure	Time frame
Quality of the feild of surgery. Timepoint: At the end of surgery. Method of measurement: Boezarrt score.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Shekoufeh Behdad

Shahid Sadoughi University of Medical Sciences

drbehdad@yahoo.com+98 35 1822 4101

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026